So Nakamura, Masayoshi Nagata, Naoya Nagaya, Takeshi Ashizawa, Hisashi Hirano, Yan Lu, Hisamitsu Ide, Shigeo Horie. The Detection and Negative Reversion of Circulating Tumor Cells as Prognostic Biomarkers for Metastatic Castration-Resistant Prostate Cancer with Bone Metastases Treated by Enzalutamide. Cancers. 2024. 16. 4
Takuro Kobayashi, Masayoshi Nagata, Yoshihiro Ikehata, Yuki Nagashima, Naoya Nagaya, Yan Lu, Shigeo Horie. T-Cell Receptor Repertoire as a Predictor of Immune-Related Adverse Events in Renal Cell Carcinoma. Current issues in molecular biology. 2023. 45. 11. 8939-8949
Naoya Nagaya, Kevin J Chua, Joshua Sterling, Shigeo Horie, Isaac Y Kim. Extended versus standard pelvic lymph node dissection yields no difference in 3-year biochemical recurrence rates. Prostate international. 2023. 11. 2. 107-112
Hisashi Hirano, Masayoshi Nagata, Naoya Nagaya, So Nakamura, Takeshi Ashizawa, Yan Lu, Haruna Kawano, Kosuke Kitamura, Yoshiro Sakamoto, Kazuhiko Fujita, et al. Bone scan index (BSI) scoring by using bone scintigraphy and circulating tumor cells (CTCs): predictive factors for enzalutamide effectiveness in patients with castration-resistant prostate cancer and bone metastases. Scientific reports. 2023. 13. 1. 8704-8704
Yoshihiro Ikehata, Yuki Nakagawa, Katsuhito Yuzawa, Tomoya Shirakawa, Azusa Yoshiyama, So Nakamura, Yuki Nagashima, Keisuke Ishikawa, Naoya Nagaya, Takeshi Ashizawa, et al. Kidney Transplantation for a Patient With Protein C Deficiency Using Activated Protein C Concentrate: A Case Report. Transplantation proceedings. 2022. 54. 10. 2754-2757
2018/11 - 2021/03 Rutgers Cancer Institute of New Jersey Research Fellow
2014/04 - 2018/03 順天堂大学 泌尿器 専門研修
2012/04 - 2014/03 順天堂大学附属静岡病院 臨床研修センター 初期臨床研修医
受賞 (1件):
European Society for Medical Oncology (ESMO) Best Poster, in the category of Genitourinary tumours, prostate, at ESMO Asia Congress 2023. Prognosis of metastatic castration resistant prostate cancer in response to chemotherapy and PSMA expression in circulating tumor cells